You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD4 lymphocytes

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Circulating Cluster of Differentiation 4 Positive 28 Null T

Not yet recruiting
  • Autoimmune Hemolytic Anemia
    • (no location specified)
    Jan 31, 2023

    Hodgkin Lymphoma, Relapse, Refractory Trial in Chapel Hill (Chemotherapy, Cell infusion)

    Not yet recruiting
    • Hodgkin Lymphoma
    • +2 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center
    Oct 13, 2023

    CD4+T Lymphocytes in Primary Nephrotic Syndrome With Infection

    Recruiting
    • Nephrotic Syndrome
    • +2 more
    • The study is an observational study without intervention
    • Zhuhai, Guangdong, China
      the fifth affiliated hospital of SUN YAT-SEN university
    Nov 20, 2022

    HIV Trial in Boston, Minneapolis, New York (Hypericin)

    Completed
    • HIV Infections
    • Boston, Massachusetts
    • +2 more
    Oct 26, 2021

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

    Completed
    Has Results
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 3, 2022

    Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

    Active, not recruiting
    • Metastatic Malignant Neoplasm in the Liver
    • Metastatic Uveal Melanoma
    • Aldesleukin
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2023

    Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Transformed Chronic

    Not yet recruiting
    • Recurrent Transformed Chronic Lymphocytic Leukemia
    • +7 more
    • Biospecimen Collection
    • +9 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    May 15, 2023

    Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma Trial in Seattle

    Recruiting
    • Recurrent Diffuse Large B-Cell Lymphoma
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 30, 2022

    Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Richter Syndrome Trial

    Not yet recruiting
    • Recurrent Transformed Chronic Lymphocytic Leukemia
    • +2 more
    • Biopsy
    • +10 more
    • Duarte, California
      City of Hope Medical Center
    Jan 3, 2023

    DLBCL, Grade 3b Follicular Lymphoma, Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial (biological, procedure, drug,

    Not yet recruiting
    • Diffuse Large B-Cell Lymphoma
    • +6 more
    • Axicabtagene Ciloleucel
    • +10 more
    • (no location specified)
    Jan 13, 2023

    DLBCL, Not Otherwise Specified, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial in Seattle

    Terminated
    Has Results
    • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
    • +5 more
    • Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 1, 2022

    HIV Trial run by the NIAID (CD4-IgG, Zidovudine, Interferon alfa-n1)

    Completed
    • HIV Infections
    • Bethesda, Maryland
      Natl Inst of Allergy & Infect Dis / Cln Ctr
    Oct 26, 2021

    Frequency and of Regulatory Function of Positive T Lymphocytes

    Completed
    • Allergic Asthma
    • +2 more
    • double positive T cells (CD4 + / CD8 +) to the specific peripheral blood of F prauznitzii analyse
    • Nantes, Pays De La Loire, France
      Nantes University Hospital
    Sep 10, 2021

    HIV Trial in Boston (Lymphocytes, Activated)

    Completed
    • HIV Infections
    • Lymphocytes, Activated
    • Boston, Massachusetts
      New England Med Ctr / Tufts Univ
    Oct 27, 2021

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte

    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • +2 more
    • Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
    • +7 more
    • Duarte, California
      City of Hope Medical Center
    Apr 5, 2023

    CD19+ Malignancies: Relapse Post-allogeneic Transplant Trial in London (Infusion of modified CAR19 T-cells (4G7-CARD T-cells))

    Active, not recruiting
    • CD19+ Malignancies: Relapse Post-allogeneic Transplant
    • Infusion of modified CAR19 T-cells (4G7-CARD T-cells)
    • London, United Kingdom
      University College London Hospital
    Jun 16, 2021

    Human Immunodeficiency Virus I Infection Trial in Lyon (Blood collection.)

    Not yet recruiting
    • Human Immunodeficiency Virus I Infection
    • Blood collection.
    • Lyon, France
      Service des maladies infectieuses et tropicales Hôpital de la Cr
    Jan 21, 2022

    Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

    Not yet recruiting
    • Metastatic Colorectal Adenocarcinoma
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 12, 2023

    HIV-1-infection, AIDS Trial in Ho Chi Minh City (Ahah Drug, Ahah Placebo)

    Completed
    • HIV-1-infection
    • AIDS
    • Ahah Drug
    • Ahah Placebo
    • Ho Chi Minh City, Vietnam
      Saigon Biopharma Company Limited
    Feb 24, 2021

    Recurrent Glioblastoma, Refractory Glioblastoma Trial in Duarte (IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory

    Recruiting
    • Recurrent Glioblastoma
    • Refractory Glioblastoma
    • IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Oct 29, 2021

    Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)

    Active, not recruiting
    • Metastatic Melanoma
    • Stage IV Cutaneous Melanoma AJCC v6 and v7
    • Aldesleukin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 2, 2022

    Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present, HLA-A*0201 Positive Cells Present Trial in Seattle (Aldesleukin,

    Terminated
    Has Results
    • Acute Myeloid Leukemia
    • +4 more
    • Aldesleukin
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 15, 2021

    Formation of HIV Cellular Reservoirs Through Expression of

    Completed
    • HIV Infections
    • Blood sample
    • Montpellier, France
      Monsef BENKIRANE
    Dec 4, 2020

    Non Small Cell Lung Cancer, Stage IV NSCLC, Recurrent Non Small Cell Lung Cancer Trial in Tampa (biological, drug, other)

    Recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • Tumor-infiltrating Lymphocytes (TIL)
    • +5 more
    • Tampa, Florida
      Moffitt Cancer Center
    Dec 28, 2022

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Active, not recruiting
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +11 more
    • Aldesleukin
    • +3 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 13, 2022